Yufan Qiu

The University of Texas MD Anderson Cancer Center

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Activated T cell-derived exosomal PD-1 attenuates PD-L1-induced immune dysfunction in triple-negative breast cancer”.

Activated T cell-derived exosomal PD-1 attenuates PD-L1-induced immune dysfunction in triple-negative breast cancer

Oncogene(2021)10.1038/s41388-021-01896-1

N/A

3.9DataRank · unranked

146 citations

Yi Yang, Ri‐Yao Yang, Chunxiao Liu, Jung-Mao Hsu, Zhou Jiang +7 more

Targeting Glycosylated PD-1 Induces Potent Antitumor Immunity

Cancer Research(2020)10.1158/0008-5472.can-19-3133

N/A

0DataRank · unranked

174 citations

Chia-Wei Li, Ezra M. Chung, Ri‐Yao Yang, Yong‐Soo Kim, Andrew H Park +15 more

Ribonuclease 7-driven activation of ROS1 is a potential therapeutic target in hepatocellular carcinoma

Journal of Hepatology(2020)10.1016/j.jhep.2020.09.030

N/A

0DataRank · unranked

32 citations

Zhengyu Zha, Chenhao Zhou, Yeh Chen, Weiya Xia, Ying‐Nai Wang +14 more

Human ribonuclease 1 serves as a secretory ligand of ephrin A4 receptor and induces breast tumor initiation

Nature Communications(2021)10.1038/s41467-021-23075-2

N/A

0DataRank · unranked

31 citations

Ying‐Nai Wang, Wenhao Yang, Weiya Xia, Yongkun Wei, Li-Chuan Chan +25 more